18
Sep
Piggy bank on money concept for business finance, investment and saving

Generics and Biosimilars Reap Huge Saving to Consumers 

Once again, AAM reports the data from the IQVIA 2023 U.S. Generic and Biosimilar Medicines Savings Report (here) which demonstrates the savings power from generic drugs and biosimilars.  The Report indicates that, in 2022, the savings realized from the use of generic and biosimilars hit a record $408 billion, of which $9.4 billion was from […]

Read More
22
Sep

AAM 2022 Report on Generic and Biosim Savings for 2021

It’s no surprise that the use of generic drugs saves consumers and health plans big money.  Now, add the savings being achieved from biosimilars (expected to increase significantly over the next year or two) and the amount is almost staggering! The just-released report, which can be found here, provides details that support the findings that […]

Read More